A functional overlap of plasminogen and MMPs regulates vascularization during placental development

Development

Volumn 130, Issue 18, 2003, Pages 4439-4450

  Solberg, Helene ^a   Rinkenberger, Julie ^b   Danø, Keld ^a   Werb, Zena ^b   Lund, Leif R ^a  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Implantation; Invasion; Matrix metalloproteinases; Plasminogen deficiency; Tissue remodeling

Indexed keywords

ILOMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PLASMINOGEN; PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DECIDUALIZATION; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; LETHALITY; MORTALITY; MOUSE; NIDATION; NONHUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; VASCULARIZATION;

ANIMALS; DIPEPTIDES; EMBRYO; EMBRYO IMPLANTATION; EMBRYO LOSS; FEMALE; FIBRIN; IN SITU HYBRIDIZATION; MALE; MATRIX METALLOPROTEINASES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PLACENTATION; PLASMINOGEN; PLASMINOGEN ACTIVATORS; PREGNANCY; PROTEASE INHIBITORS; RECEPTORS, CELL SURFACE;

ANIMALIA; MAMMALIA;

EID: 0141613710     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.00642     Document Type: Article

References (51)

1. Abrahamsohn, P. A. and Zorn, T. M. T. (1993). Implantation and decidualization in rodents. J. Exp. Zool. 266, 603-628.
2. Adamson, S. L., Lu, Y., Whiteley, K. J., Holmyard, D., Hemberger, M., Pfarrer, C. and Cross, J. C. (2002). Interaction between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev. Biol. 250, 358-373.
3. Afonso, S., Romagnano, L. and Babiarz, B. (1997). The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. Development 124, 3415-3425.
4. Alexander, C. M., Hansell, E. J., Behrendtsen, O., Flannery, M. L., Kishnani, N. S., Hawkes, S. P. and Werb, Z. (1996). Expression and function of matrix metalloproteinases and their inhibitors at the maternal boundary during mouse implantation. Development 122, 1723-1736.
5. Axelrod, H. R. (1985). Altered trophoblast functions in implantation-defective mouse embryos. Dev. Biol. 108, 185-190.
6. Balbin, M., Fueyo, A., Knauper, V., Lopez, J. M., Alvarez, J., Sanchez, L. M., Quesada, V., Bordallo, J., Murphy, G. and Lopez-Otin, C. (2001). Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J. Biol. Chem. 276, 10253-10262.
7. Baldwin, H., Shen, H. S., Yan, H.-C., DeLisser, H. M., Chung, A., Mickanin, C., Trask, T., Kirschbaum, N. E., Newman, P. J., Albelda, S. M. and Buck, C. A. (1994). Platelet endothelial cell adhesion molecule-1 (PECAM/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120, 2539-2553.
8. Baumhueter, S., Singer, M. S., Henzel, W., Hemmerich, S., Renz, M., Rosen, S. D. and Laskey, L. A. (1993). Binding of L-selectin in the vascular sialomucin CD34. Science 262, 436-438.
9. Behrendtsen, O., Alexander, C. M. and Werb, Z. (1992). Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowth. Development 114, 447-456.
10. Bini, A., Itoh, Y., Kudryk, B. J. and Nagase, H. (1996). Degradation of crosslinked fibrin by matrix metalloproteinase 3 (stromelysin-1): hydrolysis of the gamma Gly404-Ala405 peptide bond. Biochemistry 35, 13056-13063.
11. Bugge, T. H., Flick, M. J., Daugherty, C. C. and Degen, J. L. (1995a). Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9, 794-807.
12. Bugge, T. H., Suh, T. T., Flick, M. J., Daugherty, C. C., Rømer, J., Solberg, H., Ellis, V., Danø, K. and Degen, J. L. (1995b) The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J. Biol. Chem. 270, 16886-16894.
13. Bugge, T. H., Kombrinck, K. W., Flick, M. J., Daugherty, C. C., Danton, M. J. and Degen, J. L. (1996). Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87, 709-719.
14. Bugge, T. H., Lund, L. R., Kombrinck, K. K., Nielsen, B. S., Holmbäck, K., Drew, A. F., Flick, M. J., Witte, D. P., Danø, K. and Degen, J. L. (1998). Reduced metastasis of polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene 16, 3097-3104.
15. Carmeliet, P., Schoonjans, L., Kieckkens, L., Ream, B., Degen, J. L., Bronson, R., DeVos, R., van den Oord, J. J., Collen, D. and Mulligan. R. C. (1994). Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419-424.
16. Colosi, P. F., Talamantes, F. and Linzer, D. I. (1987). Molecular cloning and expression of mouse placental lactogen I complementary deoxyribonucleic acid. Mol. Endocrinol. 1, 767-776.
17. Cross, J. C., Werb, Z. and Fisher, S. J. (1994). Implantation and the placenta: key pieces of the developmental puzzle. Science 266, 1508-1518.
18. Das, S. K., Yano, S., Edwards, D. R., Nagase, H. and Dey, S. K. (1997). Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. Dev. Genet. 21, 44-54.
19. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G. and Quaranta, V. (1997). Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277, 225-228.
20. Goldfinger, L. E., Stack, M. S. and Jones, J. C. R. (1998). Processing of laminin-5 and its functional consequences: Role of plasmin and tissue-type plasminogen activator. J. Cell Biol. 141, 255-265.
21. Grobelny, D., Poncz, L. and Galardy, R. E. (1992). Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 31, 7152-7154.
22. Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R. and Weiss, S. J. (1998). Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95, 365-377.
23. Itoh, T., Tanioka, M., Yoshida, H., Nishimoto, H. and Itohara, S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051.
24. Johnsen, M., Lund, L. R., Almholt, K. and Danø, K. (1998). Cancer invasion and tissue remodeling. Common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 10, 667-671.
25. Kirby, D. R. S. (1965). The 'invasiveness' of the trophoblast. In The Early Conceptus, Normal and Abnormal (ed. W. W. Park), pp. 68-74. Edinburgh: University of St. Andrews Press.
26. Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K. and Quaranta, V. (2000). Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148, 615-624.
27. Lelongt, B., Bengatta, S., Delauche, M., Lund, L. R., Werb, Z. and Ronco, P. M. (2001). MMP-9 protects mice from anti-glomerular basement nephritis through its fibrinolytic activity. J. Exp. Med. 193, 793-802.
28. Lescisin, K. R., Varmuza, S. and Rossant, J. (1989). Isolation and characterization of a novel trophoblast-specific cDNA in the mouse. Genes Dev. 2, 1639-1649.
29. Levy, D. E., Lapierre, F., Liang, W., Ye, W., Lange, C. W., Li, X., Grobelny, D., Casabonne, M., Tyrrell, D., Holme, K., Nadzan, A. and Galardy, R. E. (1998). Matrix metalloproteinase inhibitors: A structure-activity study. J. Med. Chem. 41, 199-223.
30. Librach, C. L., Werb, Z., Fitzgerald, M. L., Chiu, K., Corwin, N. M., Esteves, R. A., Grobelny, R. A., Galardy, R., Damsky, C. H. and Fisher, S. J. (1991). 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 113, 437-449.
31. Lund, L. R., Rømer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Danø, K. and Werb, Z. (1996). Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122, 181-193.
32. Lund, L. R., Rømer, J., Bugge, T. H., Nielsen, B. S., Frandsen, T. L., Degen, J. L., Stephens, R. W. and Danø, K. (1999 . Functional overlap between two classes of matrix-degrading protease in wound healing. EMBO J. 18, 4645-4656.
33. Lund, L. R., Bjørn, S. F., Sternlicht, M. D., Nielsen, B. S., Solberg, H., Usher, P. A., Østerby, R., Christensen, I. J., Stephens, R. W., Bugge, T. H., Danø, K. and Werb, Z. (2000). Lactational competence and involution of the mammary gland require plasminogen. Development 127, 4481-4492.
34. Pepper, M. S. (2001). Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb. Vasc. Biol. 21, 1104-1117.
35. Ploplis, V. A., Carmeliet, P., Vazirzadeh, S., van Vlaenderen, I., Moons, L., Plow, E. F. and Collen, D. (1995). Effects of disruption of the plasminogen gene on thrombosis, growth and health in mice. Circulation 92, 2585-2593.
36. Reponen, P., Sahlberg, C., Huhtala, P., Hurskainen, T., Thesleff, I. and Tryggvason, K. (1992). Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J. Biol. Chem. 267, 7856-7862.
37. Rinkenberger, J. L. and Werb, Z. (2000). The labyrinthine placenta. Nat. Genet. 25, 248-249.
38. Rinkenberger, J. L., Cross, J. C. and Werb, Z. (1997). Molecular genetics of implantation in the mouse. Dev. Genet. 21, 6-20.
39. Rømer, J., Bugge, T. H., Pyke, C., Lund, L. R., Flick, M. J., Degen, J. L. and Danø, K. (1996). Impaired wound healing in mice with a disrupted plasminogen gene. Nat. Med. 2, 287-292.
40. Rossant, J. and Cross, J. C. (2001). Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2, 538-548
41. Sappino, A. P., Huarte, J., Belin, D. and Vassalli, J. D. (1989). Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J Cell Biol. 109, 2471-2479.
42. Solberg, H., Ploug, M., Høyer-Hansen, G., Nielsen, B. S. and Lund, L. R. (2001). The murine receptor for urokinase type plasminogen activator is primarily expressed in tissues actively undergoing remodeling. J. Histochem. Cytochem. 49, 236-246.
43. Sternlicht, M. D. and Werb, Z. (1999). ECM proteinases. In Guidebook to the Extracellular Matrix, Anchor and Adhesion Proteins (ed. T. Kreis and R. Vale), pp. 503-563. Oxford: Oxford University Press.
44. Suh, T. T., Holmbäck, K., Jensen, N. J., Daugherty, C. C., Small, K., Simon, D. I., Potter, S. S. and Degen, J. L. (1995). Resolution of spontaneous bleeding but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9, 2020-2033.
45. Tanaka, S. S., Togooka, Y., Sato, H., Seiko, M., Tojo, H. and Tachi, C. (1998). Expression and localization of membrane type matrix metalloproteinase-1 (MT1-MMP) in trophoblast cells of cultured mouse blastocysts and ectoplacental cones. Placenta 19, 41-48.
46. Teesalu, T., Blasi, F. and Talarico, D. (1996). Embryo implantation in the mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha2MR/LRP genes. Mech. Dev. 56, 103-106.
47. Teesalu, T., Blasi, F. and Talarico, D. (1998). Expression and function of the urokinase-type plasminogen activator during mouse hemochorial placental development. Dev. Dyn. 213, 27-38.
48. Teesalu, T., Masson, R., Basset, P., Blasi, F. and Talarico, D. (1999). Expression of matrix metalloproteinases during murine chorioallantoic placenta formation. Dev. Dyn. 214, 248-258.
49. Thomasset, N., Lochter, A., Sympson, C. J., Lund, L. R., Williams, D. R., Behrendtsen, O., Werb, Z. and Bissell, M. J. (1998). Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am. J. Pathol. 153, 457-467.
50. Vu, T. H. and Werb, Z. (2000). Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14, 2123-2133.
51. Witty, J. P., Wright, H. H. and Matrisian, L. M. (1995). Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stomelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell 6, 1287-1303.